As providers brace themselves for the new reality with the proposed 4.6% PDPM parity cuts in October 2022, they are searching for new strategies to offset these cuts amidst the continued increased ...

Most cancer treatments are based on using the maximum tolerated dose of a drug to kill as many cancer cells as possible. While this approach has led to patients achieving good responses to therapy, ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Gabby Landsverk Every time Gabby publishes a story, you’ll get an alert straight to your inbox!

Repetitive transcranial magnetic stimulation (rTMS) and other targeted, noninvasive neuromodulation approaches offer promise for treating neuropsychiatric conditions. These techniques work by ...

Chimeric antigen receptor T-cell therapy, or CAR T, is a relatively new type of therapy approved to treat several types of aggressive B cell leukemias and lymphomas. Many patients have strong ...

The first trial of the technology showed promise. But it’s about what goes into the model. On March 27, the results of the first clinical trial for a generative AI therapy bot were published, and they ...

Cell and gene therapies are exciting new modalities that have the potential to treat, and even cure, a range of diseases that may not be possible with small molecules or monoclonal antibodies. However ...

Researchers report results from their study using mathematical modeling to show that cell turnover impacts drug resistance and is an important factor that governs the success of adaptive therapy. One ...

A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the amount of blood the heart can pump and dramatically improves ...